Symptom-Onset-To-Balloon Time, ST-Segment Resolution and In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in China: From China Acute Myocardial Infarction Registry

American Journal of Cardiology

Volumn 118, Issue 9, 2016, Pages 1334-1339

  Song, Fei ^a   Yu, Mengyue ^a   Yang, Jingang ^a   Xu, Haiyan ^a   Zhao, Yanyan ^a   Li, Wei ^a   Wu, Dewei ^a   Wang, Zhifang ^b   Wang, Qingsheng ^c   Gao, Xiaojin ^a   Wang, Yang ^a   Fu, Rui ^a   Sun, Yi ^a   Gao, Runlin ^a   Yang, Yuejin ^a  

^a FUWAI HOSPITAL   (China)

^b XINXIANG CENTRAL HOSPITAL   (China)

^c FIRST HOSPITAL OF QINHUANGDAO   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BALLOON DILATATION; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHINA; CHINESE; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEART MUSCLE PERFUSION; HOSPITAL MORTALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYMPTOM ONSET TO BALLOON TIME; THERAPY DELAY; TIME; TREATMENT OUTCOME; CLINICAL TRIAL; MORTALITY; REGISTER; ST ELEVATION MYOCARDIAL INFARCTION; TIME TO TREATMENT;

CHINA; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; REGISTRIES; ST ELEVATION MYOCARDIAL INFARCTION; TIME-TO-TREATMENT; TREATMENT OUTCOME;

EID: 84992488265     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2016.07.058     Document Type: Article

References (25)

1. 1 Denktas, A.E., Anderson, H.V., Mccarthy, J., Smalling, R.W., Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv 4 (2011), 599–604.
2. 2 O'Gara, P.T., Kushner, F.G., Ascheim, D.D., Casey, D.J., Chung, M.K., de Lemos, J.A., Ettinger, S.M., Fang, J.C., Fesmire, F.M., Franklin, B.A., Granger, C.B., Krumholz, H.M., Linderbaum, J.A., Morrow, D.A., Newby, L.K., Ornato, J.P., Ou, N., Radford, M.J., Tamis-Holland, J.E., Tommaso, C.L., Tracy, C.M., Woo, Y.J., Zhao, D.X., Anderson, J.L., Jacobs, A.K., Halperin, J.L., Albert, N.M., Brindis, R.G., Creager, M.A., Demets, D., Guyton, R.A., Hochman, J.S., Kovacs, R.J., Kushner, F.G., Ohman, E.M., Stevenson, W.G., Yancy, C.W., 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), 485–510.
3. 3 Song, Y.B., Hahn, J.Y., Gwon, H.C., Kim, J.H., Lee, S.H., Jeong, M.H., The impact of initial treatment delay using primary angioplasty on mortality among patients with acute myocardial infarction: from the Korea acute myocardial infarction registry. J Korean Med Sci 23 (2008), 357–364.
4. 4 Cannon, C.P., Gibson, C.M., Lambrew, C.T., Shoultz, D.A., Levy, D., French, W.J., Gore, J.M., Weaver, W.D., Rogers, W.J., Tiefenbrunn, A.J., Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 283 (2000), 2941–2947.
5. 5 Mcnamara, R.L., Wang, Y., Herrin, J., Curtis, J.P., Bradley, E.H., Magid, D.J., Peterson, E.D., Blaney, M., Frederick, P.D., Krumholz, H.M., Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 47 (2006), 2180–2186.
6. 6 Soon, C.Y., Chan, W.X., Tan, H.C., The impact of time-to-balloon on outcomes in patients undergoing modern primary angioplasty for acute myocardial infarction. Singapore Med J 48 (2007), 131–136.
7. 7 Nallamothu, B., Fox, K.A., Kennelly, B.M., Van de Werf, F., Gore, J.M., Steg, P.G., Granger, C.B., Dabbous, O.H., Kline-Rogers, E., Eagle, K.A., Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart 93 (2007), 1552–1555.
8. 8 De Luca, G., Suryapranata, H., Zijlstra, F., van T, H.A., Hoorntje, J.C., Gosselink, A.T., Dambrink, J.H., de Boer, M.J., Symptom-onset-to-balloon time and mortality in patients with acute myocardial infarction treated by primary angioplasty. J Am Coll Cardiol 42 (2003), 991–997.
9. 9 Cho, Y.W., Jang, J.S., Jin, H.Y., Seo, J.S., Yang, T.H., Kim, D.K., Kim, D.I., Lee, S.H., Cho, Y.K., Kim, D.S., Relationship between symptom-onset-to-balloon time and long-term mortality in patients with acute myocardial infarction treated with drug-eluting stents. J Cardiol 58 (2011), 143–150.
10. 10 Rollando, D., Puggioni, E., Robotti, S., De Lisi, A., Ferrari, B.M., Vardanega, A., Pattaro, I., De Benedetti, F., Brignole, M., Symptom onset-to-balloon time and mortality in the first seven years after STEMI treated with primary percutaneous coronary intervention. Heart 98 (2012), 1738–1742.
11. 11 Nakamura, M., Yamagishi, M., Ueno, T., Hara, K., Ishiwata, S., Itoh, T., Hamanaka, I., Wakatsuki, T., Sugano, T., Kawai, K., Kimura, T., Current treatment of ST elevation acute myocardial infarction in Japan: door-to-balloon time and total ischemic time from the J-AMI registry. Cardiovasc Interv Ther 28 (2013), 30–36.
12. 12 Maeng, M., Nielsen, P.H., Busk, M., Mortensen, L.S., Kristensen, S.D., Nielsen, T.T., Andersen, H.R., Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy. Am J Cardiol 105 (2010), 1528–1534.
13. 13 Fokkema, M.L., Wieringa, W.G., van der Horst, I.C., Boersma, E., Zijlstra, F., de Smet, B.J., Quantitative analysis of the impact of total ischemic time on myocardial perfusion and clinical outcome in patients with ST-elevation myocardial infarction. Am J Cardiol 108 (2011), 1536–1541.
14. 14 Hudson, M.P., Armstrong, P.W., O'Neil, W.W., Stebbins, A.L., Weaver, W.D., Widimsky, P., Aylward, P.E., Ruzyllo, W., Holmes, D., Mahaffey, K.W., Granger, C.B., Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. Circ Cardiovasc Qual Outcomes 4 (2011), 183–192.
15. 15 Trzos, E., Kurpesa, M., Bednarkiewicz, Z., Peruga, J., Kasprzak, J., Plewka, M., Uznanska, B., Krzeminska-Pakula, M., Impact of the time to reperfusion on early outcomes in patients with acute myocardial infarction undergoing primary angioplasty. Kardiol Pol 65 (2007), 1296–1304 1305–1306.
16. 16 Xu, H., Li, W., Yang, J., Wiviott, S.D., Sabatine, M.S., Peterson, E.D., Xian, Y., Roe, M.T., Zhao, W., Wang, Y., Tang, X., Jia, X., Wu, Y., Gao, R., Yang, Y., CAMI Registry study group. The China Acute Myocardial Infarction (CAMI) Registry: a national long-term Registry-Research-Education integrated platform for exploring acute myocardial infarction in China. Am Heart J 175 (2016), 193–201e3.
17. 17 Eagle, K.A., Nallamothu, B.K., Mehta, R.H., Granger, C.B., Steg, P.G., Van de Werf, F., Lopez-Sendon, J., Goodman, S.G., Quill, A., Fox, K.A., Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J 29 (2008), 609–617.
18. 18 Vemulapalli, S., Zhou, Y., Gutberlet, M., Kumar, A.S., Mills, J.S., Blaxill, J., Smalling, R., Ohman, E.M., Patel, M.R., Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial). Am J Cardiol 112 (2013), 911–917.
19. 19 Solhpour, A., Chang, K.W., Arain, S.A., Balan, P., Loghin, C., Mccarthy, J.J., Vernon, A.H., Smalling, R.W., Ischemic time is a better predictor than door-to-balloon time for mortality and infarct size in ST-elevation myocardial infarction. Catheter Cardiovasc Interv 87 (2016), 1194–1200.
20. 20 Baek, Y.S., Park, S.D., Kim, S.H., Lee, M.J., Shin, S.H., Kim, D.H., Kwan, J., Park, K.S., Woo, S.I., Clinical and angiographic predictors of microvascular dysfunction in ST-Segment elevation myocardial infarction. Yonsei Med J 56 (2015), 1235–1243.
21. 21 Farkouh, M.E., Reiffel, J., Dressler, O., Nikolsky, E., Parise, H., Cristea, E., Baran, D.A., Dizon, J., Merab, J.P., Lansky, A.J., Mehran, R., Stone, G.W., Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report. Circ Cardiovasc Interv 6 (2013), 216–223.
22. 22 Menees, D.S., Peterson, E.D., Wang, Y., Curtis, J.P., Messenger, J.C., Rumsfeld, J.S., Gurm, H.S., Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med 369 (2013), 901–909.
23. 23 Hannan, E.L., Zhong, Y., Jacobs, A.K., Holmes, D.R., Walford, G., Venditti, F.J., Stamato, N.J., Sharma, S., King, S.R., Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for ST-segment elevation myocardial infarction. Am J Cardiol 106 (2010), 143–147.
24. 24 Brodie, B.R., Gersh, B.J., Stuckey, T., Witzenbichler, B., Guagliumi, G., Peruga, J.Z., Dudek, D., Grines, C.L., Cox, D., Parise, H., Prasad, A., Lansky, A.J., Mehran, R., Stone, G.W., When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trials. J Am Coll Cardiol 56 (2010), 407–413.
25. 25 Brodie, B.R., Hansen, C., Stuckey, T.D., Richter, S., Versteeg, D.S., Gupta, N., Downey, W.E., Pulsipher, M., Door-to-balloon time with primary percutaneous coronary intervention for acute myocardial infarction impacts late cardiac mortality in high-risk patients and patients presenting early after the onset of symptoms. J Am Coll Cardiol 47 (2006), 289–295.